Gaurav Kharya/LinkedIn
Jun 24, 2026, 16:49
Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
Gaurav Kharya, Director, Dept. of Bone Marrow Transplant and Cellular Therapy at Indraprastha Apollo Hospitals, shared a post on LinkedIn:
“Some issues cannot wait.
Access to safe blood for people who depend on regular transfusions is one of them-because delays can have life-threatening consequences.
My article in The Week looks at why ensuring timely and safe blood access remains critical, and why sustained attention and action are needed for those who rely on it every day.
Indraprastha Apollo Hospitals, New Delhi Cellogen Therapeutics
Bridging the gaps: Safe blood, lifesaving care, and a cure for sickle cell disease – The Week.”
Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering